2023 another banner year Duke Heart:

- 161 ❤️TX IN THE CALENDAR YEAR!!!!

-2000th ❤️tx

2024? 185??? 2025? 200???

❤️‍🔥❤️‍🔥❤️‍🔥

Adam DeVore, MD, MHS Chet Patel Robert Mentz, MD Richa Agarwal Michael Felker camwolfe Manesh Patel Sharon McCartney Brandi Bottiger Alina Nicoara

So excited about this Srihari S. Naidu, MD. Will work to make this a great issue! Please reach out with your ideas and your papers! Abdulla A. Damluji, MD, PhD Ajar Kochar Michael Nanna Manesh Patel Sunil V. Rao Babar Basir

To Jason N. Katz who deserves all the thanks in the world for the many contributions to Duke Heart.

Great conference, great people!

SELECT Trial has practicing changing results but also many thought provoking questions. Pleased to write the Editorial to put the study in perspective in NEJM with T Powell-Wiley #AHA23 nejm.org/doi/full/10.10…

SELECT “establishes overweight and obesity as a modifiable risk factor for cardiovascular disease” -AM Lincoff 🔥 nejm.org/doi/full/10.10… NEJM #AHA23 AHA Science

DAPA-MI showed improved outcomes with dapagliflozin post MI in patients with reduced EF. #AHA23

And away we go AHA Science

Join us at next LBCT sessions:

DAPA-MI
MINT
ORBITA-2

Go science!

Saint Luke's Mid America Heart Institute

Great Debates in Weight Management: GLP1RA: For Who? For What? And How?

A perfect follow-up to this morning’s SELECT, and a don’t miss!

Sat Nov 11th
3:15pm
Room 204A

#AHA2023

We women cardiologists are still few in number, but we top the list of specialists who would choose medicine again! #ACCWIC American College of Cardiology Women as One

Succinct summary of the HEART-FID trial and clinical implications touchCARDIO
IV iron for HFrEF + iron deficiency
Duke Clinical Research Institute Adrian “WE NEED RCTS!” Hernandez Javed Butler Justin Ezekowitz Josephine Harrington, MD Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Anu Lala-Trindade Vanessa Blumer, MD
touchcardio.com/?p=40542

Original Article: Ferric Carboxymaltose in Heart Failure with Iron Deficiency (HEART-FID trial) nej.md/44rzIe4

Editorial: Treating Iron Deficiency in Heart Failure nej.md/3subhjb

#ESCCongress #cardiology

HEART-FID (FCM in HFrEF + ID) on behalf of huge team #ESCCongress European Society of Cardiology
FCM safe w modest benefit in hierarchical endpt (mortality, HF hosp, 6MWD)-Didn't meet pre-specified level of stat signif
nejm.org/doi/full/10.10…
Pooled FCM data to contextualize
academic.oup.com/eurheartj/adva…

Eager to share HEART-FID results on Sat AM #ESCCongress European Society of Cardiology
As a teaser, here are the baseline characteristics of the pts-contextualized w prior trials
See you in Amsterdam!!
Josephine Harrington, MD Javed Butler Adrian “WE NEED RCTS!” Hernandez Justin Ezekowitz AmericanHeartJ
sciencedirect.com/science/articl…

Excited for #ESC2023 in just 2 wk!

Honored to share HEART-FID results on Sat, Aug 26 in Hotline 2 at 8:30am - on behalf of incredible investigator team & pts

Largest IV iron trial in HF

Followed by pooled FCM analysis

See ya there!

#HID2023
So great to see the meeting start with a session on Heart Disease in Women with 3 amazing speakers - AnnabelleVolgman MD Erin D. Michos, M.D. & Neha Pagidipati!
🙏🏻 to Yehuda Handelsman, MD, FACP, FNLA, MACE, Mikhail Kosiborod for prioritizing this topic!
Healio Heart in Diabetes 🫀 Duke Clinical Research Institute Johns Hopkins Ciccarone Center RUSH

Amazing kickoff talks from the wonderful ⁦⁦Adrienne Volgmann⁩ , ⁦Erin D. Michos, M.D.⁩ and Neha Pagidipati at ⁦Heart in Diabetes 🫀⁩ discussing heart disease in women. Key takeaways: microvascular issues, especially with T2DM are a huge problem, menopause sx are NOT benign

#ICYMI : DOACs vs Warfarin: COMBINE AF Kidney Analysis @jlharrington_md #AHAJournals

An incredible and well-deserved honor!

Clinical Profile, Health Care Costs, and Outcomes of Patients Hospitalized for Heart Failure With Severely Reduced Ejection Fraction. #AHAJournals @jlharrington_md @GCFMD Larry A. Allen, MD @NMHHeartdoc Michael Felker Steve Greene ahajrnls.org/3C04I9f